Endogenous galectin-3 controls experimental malaria in a species-specific manner

Area of Science:

• Immunology
• Parasitology
• Glycobiology

Background:

• Galectins are conserved glycan-binding proteins crucial for immune responses.
• Galectin-3 plays a role in pathogen recognition and host-pathogen interactions.
• The in vivo role of galectin-3 in host defense against malaria parasites is not well understood.

Purpose of the Study:

• To investigate the impact of galectin-3 deficiency on malaria parasite infections in vivo.
• To determine the species-specific role of galectin-3 in host defense mechanisms against Plasmodium species.

Main Methods:

• Utilized genetically modified mice lacking galectin-3 (Lgals3(-/-)).
• Infected mice with three distinct species of rodent malaria parasites: Plasmodium yoelii, Plasmodium berghei, and Plasmodium chabaudi.
• Quantified parasitemia and measured anti-Plasmodium antibody titers (IgG2b isotype).

Main Results:

• Galectin-3 deficiency had a marginal effect on Plasmodium chabaudi parasitemia and no effect on Plasmodium berghei parasitemia.
• Lack of galectin-3 significantly reduced Plasmodium yoelii parasitemia in mice.
• Reduced P. yoelii parasitemia in Lgals3(-/-) mice correlated with higher anti-P. yoelii MSP1(19) IgG2b antibody titers.

Conclusions:

• Endogenous galectin-3 exhibits a species-specific role in controlling malaria parasite infections.
• Galectin-3 influences the modulation of antibody responses during Plasmodium infections.
• These findings highlight the complexity of host-pathogen interactions involving galectins.